|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Loss for the year | |||||
| Depreciation | |||||
| Share-based compensation expense | |||||
| Net finance (income)/expense | |||||
| Finance income | |||||
| Finance expense | |||||
| Movement of expected credit loss | |||||
| Foreign exchange (gain)/loss | |||||
| Movement in working capital | |||||
| Cash flows used in operating activities | |||||
| Finance expense paid | |||||
| Finance income received | |||||
| Net cash used in operating activities | |||||
| Cash flows from/(used in) investing activities | |||||
| Purchase of property, plant and equipment | |||||
| Purchase of marketable securities | |||||
| Purchase of other financial assets | |||||
| Proceeds from sale of other financial asset | |||||
| Proceeds from redemptions and disposals of marketable securities | |||||
| Cash flows from/(used in) investing activities | |||||
| Cash flows from/(used in) financing activities | |||||
| Payment of lease liability | |||||
| Proceeds from equity public offering | |||||
| Transaction costs from equity public offering | |||||
| Proceeds from share issuances | |||||
| Net cash flows from/(used in) financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Impact of foreign exchange on cash and cash equivalents | |||||
| Cash and cash equivalents at the end of the year | |||||
Loading...
